Status:
UNKNOWN
To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients With Neuralgia of Various Origins
Lead Sponsor:
Bunker Industria Farmaceutica Ltda.
Conditions:
Neuralgia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To evaluate the efficacy and tolerability of Vitatonus Dexa compared with dexamethasone in the signs and symptoms of neuralgia of various origins. Clinical study, randomized prospective and random in...
Eligibility Criteria
Inclusion
- Patients who consent to participate in the study by signing the ICF;
- Patients of any ethnic group of both sexs aged over 18 years;
- Patients with clinical diagnosis of neuralgia of various origins.
- Patients who present scores on the Visual Analogue Scale (VAS) greater than or equal to 4 for PAIN.
Exclusion
- Patients with known hypersensitivity to lidocaine and thiamine or any component of the formula;
- Pregnant women and nursing mothers;
- Hypertensive or cardiac patients;
- Patients with history of ulcers in the stomach or duodenum, diabetes mellitus or severe infections;
- Patients who use levodopa, salicylates, colchicine, aminoglycosides, chloramphenicol, anticonvusivantes or potassium supplement.
- Patient with a history of alcohol or use illicit drugs;
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT00944502
Start Date
October 1 2009
End Date
December 1 2009
Last Update
July 24 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculdade de Medicina do ABC
Santo André, São Paulo, Brazil, 09060650